Found: 95
Select item for more details and to access through your institution.
Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 29, p. 16041, doi. 10.1002/ange.202101328
- By:
- Publication type:
- Article
Mutant‐Selective Allosteric EGFR Degraders are Effective Against a Broad Range of Drug‐Resistant Mutations.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 34, p. 14589, doi. 10.1002/ange.202003500
- By:
- Publication type:
- Article
Development of CDK2 and CDK5 Dual Degrader TMX‐2172.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 33, p. 13969, doi. 10.1002/ange.202004087
- By:
- Publication type:
- Article
Development of Dual and Selective Degraders of Cyclin‐Dependent Kinases 4 and 6.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 19, p. 6387, doi. 10.1002/ange.201901336
- By:
- Publication type:
- Article
Discovery of a Highly Potent and Broadly Effective Epidermal Growth Factor Receptor and HER2 Exon 20 Insertion Mutant Inhibitor.
- Published in:
- Angewandte Chemie, 2018, v. 130, n. 36, p. 11803, doi. 10.1002/ange.201805187
- By:
- Publication type:
- Article
High-throughput kinase profiling as a platform for drug discovery.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 391, doi. 10.1038/nrd2541
- By:
- Publication type:
- Article
Targeting transcription in heart failure via CDK7/12/13 inhibition.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31541-8
- By:
- Publication type:
- Article
When Kinases Meet PROTACs.
- Published in:
- Chinese Journal of Chemistry, 2018, v. 36, n. 10, p. 971, doi. 10.1002/cjoc.201800293
- By:
- Publication type:
- Article
Discovery of a Highly Potent and Broadly Effective Epidermal Growth Factor Receptor and HER2 Exon 20 Insertion Mutant Inhibitor.
- Published in:
- Angewandte Chemie International Edition, 2018, v. 57, n. 36, p. 11629, doi. 10.1002/anie.201805187
- By:
- Publication type:
- Article
Therapeutic Targeting of Oncogenic K-Ras by a Covalent Catalytic Site Inhibitor.
- Published in:
- Angewandte Chemie International Edition, 2014, v. 53, n. 1, p. 199, doi. 10.1002/anie.201307387
- By:
- Publication type:
- Article
A Discovery Strategy for Selective Inhibitors of c-Src in Complex with the Focal Adhesion Kinase SH3/SH2-binding Region.
- Published in:
- Chemical Biology & Drug Design, 2015, v. 86, n. 2, p. 144, doi. 10.1111/cbdd.12473
- By:
- Publication type:
- Article
The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 2, p. 566, doi. 10.3390/ijms22020566
- By:
- Publication type:
- Article
Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 5, p. 2037, doi. 10.1172/JCI72522
- By:
- Publication type:
- Article
Anti‐SARS‐CoV‐2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID‐19 therapy.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28157
- By:
- Publication type:
- Article
Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases.
- Published in:
- Biochemical Journal, 2014, v. 457, n. 1, p. 215, doi. 10.1042/BJ20131152
- By:
- Publication type:
- Article
STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells.
- Published in:
- eLife, 2020, p. 1, doi. 10.7554/eLife.53003
- By:
- Publication type:
- Article
MELK is not necessary for the proliferation of basal-like breast cancer cells.
- Published in:
- eLife, 2017, p. 1, doi. 10.7554/eLife.26693
- By:
- Publication type:
- Article
Molecular basis for cooperative binding and synergy of ATP-site and allosteric EGFR inhibitors.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30258-y
- By:
- Publication type:
- Article
Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation
- Published in:
- Nature Communications, 2021, v. 12, p. 1, doi. 10.1038/s41467-021-26935-z
- By:
- Publication type:
- Article
Extracellular signal--regulated kinase 5 promotes acute cellular and systemic inflammation.
- Published in:
- Science Signaling, 2015, v. 8, n. 391, p. 1, doi. 10.1126/scisignal.aaa3206
- By:
- Publication type:
- Article
The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma.
- Published in:
- Science Signaling, 2014, v. 7, n. 349, p. 1, doi. 10.1126/scisignal.2005470
- By:
- Publication type:
- Article
Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 7, p. 630, doi. 10.1038/nbt.2620
- By:
- Publication type:
- Article
Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms.
- Published in:
- Nature Medicine, 2011, v. 17, n. 9, p. 1116, doi. 10.1038/nm.2402
- By:
- Publication type:
- Article
TSC1 involvement in bladder cancer: diverse effects and therapeutic implications.
- Published in:
- Journal of Pathology, 2013, v. 230, n. 1, p. 17, doi. 10.1002/path.4176
- By:
- Publication type:
- Article
Activation of tyrosine kinases by mutation of the gatekeeper threonine.
- Published in:
- Nature Structural & Molecular Biology, 2008, v. 15, n. 10, p. 1109, doi. 10.1038/nsmb.1486
- By:
- Publication type:
- Article
Therapeutic Targeting of Oncogenic K-Ras by a Covalent Catalytic Site Inhibitor.
- Published in:
- Angewandte Chemie, 2014, v. 126, n. 1, p. 203, doi. 10.1002/ange.201307387
- By:
- Publication type:
- Article
Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128364
- By:
- Publication type:
- Article
Interleukin-6 Secretion by Astrocytes Is Dynamically Regulated by PI3K-mTOR-Calcium Signaling.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0092649
- By:
- Publication type:
- Article
BAY61-3606 Affects the Viability of Colon Cancer Cells in a Genotype-Directed Manner.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0041343
- By:
- Publication type:
- Article
Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0020226
- By:
- Publication type:
- Article
Inhibitor-Sensitive FGFR1 Amplification in Human Non- Small Cell Lung Cancer.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0020351
- By:
- Publication type:
- Article
Allosteric Interactions between the Myristate- and ATP-Site of the Abl Kinase.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0015929
- By:
- Publication type:
- Article
Dual targeting of salt inducible kinases and CSF1R uncouples bone formation and bone resorption.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.67772
- By:
- Publication type:
- Article
Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11429-w
- By:
- Publication type:
- Article
CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09703-y
- By:
- Publication type:
- Article
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 1, p. 27, doi. 10.1002/1878-0261.12673
- By:
- Publication type:
- Article
Front Cover: Development and Characterization of Selective FAK Inhibitors and PROTACs with In Vivo Activity (ChemBioChem 19/2023).
- Published in:
- ChemBioChem, 2023, v. 24, n. 19, p. 1, doi. 10.1002/cbic.202300535
- By:
- Publication type:
- Article
Development and Characterization of Selective FAK Inhibitors and PROTACs with In Vivo Activity.
- Published in:
- ChemBioChem, 2023, v. 24, n. 19, p. 1, doi. 10.1002/cbic.202300141
- By:
- Publication type:
- Article
Cover Picture: Chemical Interrogation of the Malaria Kinome (ChemBioChem 13/2014).
- Published in:
- ChemBioChem, 2014, v. 15, n. 13, p. 1841, doi. 10.1002/cbic.201490045
- By:
- Publication type:
- Article
Chemical Interrogation of the Malaria Kinome.
- Published in:
- ChemBioChem, 2014, v. 15, n. 13, p. 1920, doi. 10.1002/cbic.201400025
- By:
- Publication type:
- Article
Fluorescent Visualization of Src by Using Dasatinib-BODIPY.
- Published in:
- ChemBioChem, 2014, v. 15, n. 9, p. 1317, doi. 10.1002/cbic.201402010
- By:
- Publication type:
- Article
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M.
- Published in:
- Nature, 2009, v. 462, n. 7276, p. 1070, doi. 10.1038/nature08622
- By:
- Publication type:
- Article
Activating mutations in ALK provide a therapeutic target in neuroblastoma.
- Published in:
- Nature, 2008, v. 455, n. 7215, p. 975, doi. 10.1038/nature07397
- By:
- Publication type:
- Article
Discovery of Potent Degraders of the Dengue Virus Envelope Protein.
- Published in:
- Advanced Science, 2024, v. 11, n. 40, p. 1, doi. 10.1002/advs.202405829
- By:
- Publication type:
- Article
Synergistic Anti-Tumor Effect of Combining Selective CDK7 and BRD4 Inhibition in Neuroblastoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.773186
- By:
- Publication type:
- Article
A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 774, doi. 10.1093/neuonc/now261
- By:
- Publication type:
- Article
Systematic analysis of BRAF<sup>V</sup><sup>600E</sup> melanomas reveals a role for JNK/c-Jun pathway in adaptive resistance to drug-induced apoptosis.
- Published in:
- Molecular Systems Biology, 2015, v. 11, n. 3, p. n/a, doi. 10.15252/msb.20145877
- By:
- Publication type:
- Article
Salt-inducible kinase 1 maintains HDAC7 stability to promote pathologic cardiac remodeling.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells.
- Published in:
- Proteomics, 2021, v. 21, n. 13, p. 1, doi. 10.1002/pmic.202000098
- By:
- Publication type:
- Article